New Study to Investigate CBD Effects on Creative Flow

March 9, 2020 16:00:09

Cannabidiol, better known as CBD, is a chemical that’s taken the world completely by storm. Extracted from hemp, it was legalized in 2018 when the Farm Bill released industrial hemp from decades of prohibition. And in its first years of legal sales, the CBD industry is worth millions of dollars, with experts estimating it will hit $20 billion by 2024.

CBD’s insane popularity can be traced back to its potent medical properties. The hemp extract is said to be effective against a wide variety of ailments, with users claiming it was able to stave off the symptoms of conditions like anxiety, nausea, chronic pain, and high blood pressure. Although a lot of these claims haven’t been verified yet, users swear by…


About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published:

Do you have a questions or are you interested in working with CNW? Ask Our Editor

Denver, Colorado
303.498.7722 Office

CBDWire is part of the InvestorBrandNetwork.